Marker Therapeutics, Inc. (NASDAQ:MRKR) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joshua N. Silverman Other companies: Femasys Inc. (Director · Since at least Nov 21, 2023); PharmaCyte Biotech, Inc. (Interim Chief Executive Officer, President, and Director · Since at least Aug 15, 2022); TAO Synergies Inc. (Executive Chairman · Since at least Jun 4, 2021); Petros Pharmaceuticals Inc (Vice-Chairman of the Board · Since at least Dec 1, 2020); Q/C Technologies, Inc. (Executive Chairman · Since at least Sep 6, 2018); Fabric.AI, Inc. (Chief Executive Officer, Director · Since at least Aug 15, 2016); Neurotrope Inc (Director · Aug 4, 2016 – Dec 1, 2020 · Past); Protagenic Therapeutics, Inc. (Director · Feb 12, 2016 – Feb 21, 2020 · Past); MGT Capital Investments, Inc. (Director · Dec 31, 2015 – Dec 31, 2015 · Past); National Holdings Corporation (Director · Jul 28, 2014 – Sep 12, 2016 · Past) | Director · Nov 28, 2016 – Oct 16, 2018 · Past |
| Steven A. Elms Other companies: Elevation Oncology Inc (Director · Since at least Jun 17, 2022); ADMA Biologics Inc (Chairman · Since at least Feb 13, 2012); Zosano Pharma Corp (Director · May 17, 2018 – Jun 10, 2021 · Past); T2 Biosystems, Inc. (Director · Dec 9, 2015 – Dec 9, 2015 · Past); Cidara Therapeutics Inc (Director · Apr 14, 2015 – Apr 20, 2015 · Past); Loxo Oncology Inc (Director · Jul 31, 2014 – Feb 15, 2019 · Past); Ambit Biosciences Corp (Director · May 15, 2013 – Sep 2, 2014 · Past); Pernix Therapeutics Holdings Inc (Director · Aug 31, 2011 – May 26, 2016 · Past) | Director · Since at least Aug 6, 2019 |
| Frederick G. Wasserman Other companies: DLH Holdings Corp. (Chairman of the Board of Directors · Since at least Oct 3, 2007); National Holdings Corporation (Director · Sep 12, 2016 – Sep 12, 2016 · Past); SMTC Corporation (Director · Feb 4, 2015 – Apr 5, 2021 · Past); Gilman Ciocia Inc (Director · Oct 3, 2008 – Oct 15, 2013 · Past); Breeze-Eastern Corp (Director · Sep 13, 2007 – Jan 4, 2016 · Past); Crown Crafts, Inc. (Director · Aug 29, 2007 – Aug 12, 2009 · Past); MAM Software Group Inc (Director · Jul 17, 2007 – Oct 21, 2019 · Past) | Director · Jan 26, 2016 – Jun 8, 2021 · Past |
| Paul Edward Walker Other companies: NeueHealth Inc (Director · Since at least Oct 2, 2025); Trillium Therapeutics Inc (Director · Jan 1, 2021 – Nov 17, 2021 · Past); Regulus Therapeutics Inc (Director · May 7, 2019 – May 7, 2019 · Past); Trevi Therapeutics, Inc. (Director · May 7, 2019 – May 7, 2019 · Past); Allakos Inc (Director · Jul 18, 2018 – May 15, 2025 · Past); Tesaro Inc (Director · Jun 27, 2012 – Jun 2, 2014 · Past) | Director · Oct 17, 2018 – Oct 17, 2018 · Past |
| John N Bonfiglio Other companies: Qrons Inc (Chief Operating Officer · Jul 1, 2019 – Jul 1, 2019 · Past); Genprex, Inc. (Director · Feb 12, 2019 – Feb 12, 2019 · Past); Oragenics Inc. (President and CEO, Director · May 25, 2011 – Aug 13, 2014 · Past); Harrow, Inc. (President and CEO, Director · Oct 20, 2010 – Oct 20, 2010 · Past) | President and COO, Director · Jul 23, 2015 – Mar 9, 2017 · Past |
| Katharine Knobil Other companies: Korro Bio, Inc. (Director · Since at least Aug 26, 2024); Pliant Therapeutics, Inc. (Director · Since at least Sep 14, 2022); Arena Pharmaceuticals Inc (Director · Jun 12, 2020 – Mar 11, 2022 · Past); Kaleido Biosciences, Inc. (Chief Medical Officer · Feb 27, 2019 – Oct 15, 2020 · Past) | Chief Medical Officer, Altesa BioSciences, Inc. · Since at least Dec 8, 2021 |
| Eliot M Lurier Other companies: Mustang Bio, Inc. (Interim CFO · Apr 18, 2022 – Apr 18, 2022 · Past); Tenax Therapeutics, Inc. (Interim CFO · Oct 29, 2021 – Oct 29, 2021 · Past); Interleukin Genetics Inc (Chief Financial Officer · Mar 23, 2011 – Oct 22, 2013 · Past) | Interim CFO · Jun 30, 2023 – Jun 30, 2023 · Past |
| Glynn Wilson Other companies: Caring Brands, Inc. (Chief Executive Officer, Director · Since at least Oct 30, 2025); Cadrenal Therapeutics, Inc. (Board Member · Since at least Jan 19, 2023); Bonk, Inc. (Former CSO, Chairman, Director · Oct 30, 2020 – Mar 1, 2024 · Past) | Director · Jun 8, 2007 – Oct 9, 2018 · Past |
| Sherry Grisewood Other companies: PetVivo Holdings Inc (Director · Aug 20, 2018 – Jan 15, 2019 · Past); Oncolix Inc (Director · Jun 26, 2018 – Jun 26, 2018 · Past) | Director · Nov 12, 2015 – Oct 16, 2018 · Past |
| Ann M Leen Other companies: Kalaris Therapeutics, Inc. (Chief Scientific Officer · Jul 29, 2020 – Aug 16, 2022 · Past) | Chief Scientific Officer · Dec 21, 2018 – Feb 15, 2020 · Past |
| Denis Corin Other companies: Q BioMed Inc (Chief Executive Officer, Director · Apr 21, 2015 – May 26, 2022 · Past) | President, Director · Jun 8, 2007 – Feb 17, 2012 · Past |
| John Robert Wilson Other companies: Kalaris Therapeutics, Inc. (Director · Jul 29, 2020 – May 25, 2021 · Past) | Director · Oct 17, 2018 – Jun 6, 2023 · Past |
| Juan F. Vera Other companies: Kalaris Therapeutics, Inc. (Director · Jul 29, 2020 – Jun 6, 2024 · Past) | Chief Executive Officer & Co-Founder, Marker Therapeutics · Since at least Oct 17, 2018 |
| Kathryn Penkus Corzo Other companies: Matinas BioPharma Holdings, Inc. (Director · Nov 1, 2021 – Nov 1, 2023 · Past) | President and Chief Operating Officer, bit.bio · Since at least Oct 31, 2025 |
| Ken Moseley Other companies: Bellicum Pharmaceuticals Inc (Sr. VP and General Counsel · Dec 17, 2014 – Jan 3, 2018 · Past) | General Counsel · Dec 21, 2018 – Dec 21, 2018 · Past |
| Norman David Eansor Other companies: Bio-Techne Corp (President-Protein Sciences · Jun 12, 2019 – Nov 12, 2021 · Past) | Director · Since at least May 9, 2019 |
| Anna Szymanska | Vice President, Quality · Mar 10, 2020 – Feb 27, 2023 · Past |
| Anthony H Kim | Chief Financial Officer · Nov 27, 2018 – Mar 24, 2022 · Past |
| David Eansor | Director · Since at least Nov 5, 2026 |
| Edmund Cheung | Vice President, Human Resources · Since at least Nov 4, 2026 |
| Gerald Garrett | Vice President, Clinical Ops. · Mar 10, 2020 – Feb 17, 2022 · Past |
| Lynn DePippo | Director · Sep 7, 2010 – Sep 7, 2010 · Past |
| Mark Reddish | Director · Feb 17, 2012 – Oct 16, 2018 · Past |
| Mary Newman | Head of Regulatory Affairs · Since at least Nov 5, 2026 |
| Michael Loiacono | Chief Accounting Officer · Aug 25, 2016 – Feb 27, 2023 · Past |
| Mythili Koneru | Chief Medical Officer · May 9, 2019 – Feb 27, 2023 · Past |
| Nadia Agopyan | SVP, Regulatory Affairs · Aug 15, 2019 – Feb 27, 2023 · Past |
| Patricia Allison | Head of Clinical Operations · Since at least Nov 4, 2026 |
| Patrick A McGowan | Secretary, Treasurer & CFO, Director · Jun 8, 2007 – Jun 8, 2007 · Past |
| Peter L Hoang | President and CEO, Director · Aug 14, 2019 – Mar 24, 2022 · Past |
| Steve Elms | Managing Partner, Aisling Capital · Since at least Nov 4, 2026 |
| Tracy A Moore | Chief Financial Officer, Director · Aug 24, 2009 – Oct 14, 2009 · Past |
| Tsvetelina P Hoang | VP, Research and Development · Dec 21, 2018 – Feb 27, 2023 · Past |